Clinically relevant atovaquone-resistant human malaria parasites fail to transmit by mosquito

Long-acting injectable medications, such as atovaquone, offer the prospect of a “chemical vaccine” for malaria, combining drug efficacy with vaccine durability. However, selection and transmission of drug-resistant parasites is of concern. Laboratory studies have indicated that atovaquone resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Balta, Victoria A., Stiffler, Deborah, Sayeed, Abeer, Tripathi, Abhai K., Elahi, Rubayet, Mlambo, Godfree, Bakshi, Rahul P., Dziedzic, Amanda G., Jedlicka, Anne E., Nenortas, Elizabeth, Romero-Rodriguez, Keyla, Canonizado, Matthew A., Mann, Alexis, Owen, Andrew, Sullivan, David J., Prigge, Sean T., Sinnis, Photini, Shapiro, Theresa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570281/
https://www.ncbi.nlm.nih.gov/pubmed/37828012
http://dx.doi.org/10.1038/s41467-023-42030-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570281/
https://www.ncbi.nlm.nih.gov/pubmed/37828012
http://dx.doi.org/10.1038/s41467-023-42030-x

Ejemplares similares